|
業務類別
|
Medical Devices |
|
業務概覽
|
CytoSorbents Corp is a leader in blood purification for the treatment of life-threatening conditions in the intensive care unit and cardiac surgery. CytoSorbent's proprietary blood purification technologies are based on biocompatible, high-porous polymer beads that can actively remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption. CytoSorbent's technologies are used in several broad applications. Specifically, two important applications are: the removal of blood thinners during and after cardiothoracic surgery to reduce the risk of severe bleeding, and the removal of inflammatory agents and toxins in common critical illnesses that can cause massive inflammation, organ failure, and patient death. Geographically, in the USA, Germany, and Others. |
| 公司地址
| 305 College Road East, Princeton, NJ, USA, 08540 |
| 電話號碼
| +1 732 329-8885 |
| 傳真號碼
| +1 732 329-8650 |
| 公司網頁
| https://www.cytosorbents.com |
| 員工數量
| 129 |
| Mr. Peter J. Mariani |
Chief Financial Officer and Principal Accounting Officer |
美元 442.00K |
25/06/2026 |
| Mr. Vincent J. Capponi, M.S. |
President and Chief Operating Officer |
美元 460.04K |
25/06/2026 |
| Dr. Phillip P. Chan, M.D.,PhD |
Chief Executive Officer and Director |
美元 502.17K |
25/06/2026 |
| Dr. Efthymios Nikolaos Deliargyris, M.D. |
Chief Medical Officer |
美元 432.59K |
25/06/2026 |
|
|
| Dr. Edward R. Jones, M.B.A.,M.D. |
Independent Director |
25/06/2026 |
| Dr. Phillip P. Chan, M.D.,PhD |
Chief Executive Officer and Director |
25/06/2026 |
| Mr. Alan D. Sobel, C.P.A. |
Independent Director |
25/06/2026 |
| Mr. Michael G. Bator |
Chairman of the Board |
25/06/2026 |
| Ms. Jiny Kim, M.B.A. |
Independent Director |
25/06/2026 |
|
|
|
|
